Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining (Q45277795)
scientific article
Language:
Current Data About Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining
(P31) (Q13442814)
(P248)
(P698) 2565403
(P813) Monday, December 11, 2017

(P304) 696-701
(P248)
(P698) 2565403
(P813) Monday, December 11, 2017

(P407) (Q1860)

(P433) 9
(P248)
(P698) 2565403
(P813) Monday, December 11, 2017

(P478) 81
(P248)
(P698) 2565403
(P813) Monday, December 11, 2017

(P577) Monday, May 1, 1989
(P248)
(P698) 2565403
(P813) Monday, December 11, 2017

(P921) (Q18936)

(Q128581)
(P887)

(P1433) (Q400279)
(P248)
(P698) 2565403
(P813) Monday, December 11, 2017

(P1476) "Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining" (language: en)
(P248)
(P698) 2565403
(P813) Monday, December 11, 2017

(P2093) Salmon SE
(P1545) 1
(P248)
(P698) 2565403
(P813) Monday, December 11, 2017

Grogan TM
(P1545) 2
(P248)
(P698) 2565403
(P813) Monday, December 11, 2017

Miller T
(P1545) 3
(P248)
(P698) 2565403
(P813) Monday, December 11, 2017

Scheper R
(P1545) 4
(P248)
(P698) 2565403
(P813) Monday, December 11, 2017

Dalton WS
(P1545) 5
(P248)
(P698) 2565403
(P813) Monday, December 11, 2017

other details